202342769
Case History and Clinical
Findings
PATIENT CAME
WITH C/O HEAVY AND PROLONGED CYCLES SINCE 1 MONTH
PATIENT
WAS APPARENTLY ASYMPTOMATIC 1 MONTH BACK THEN SHE DEVELOPED 1 MONTH AMENORRHEA FOLLOWED BY HEAVY AND
PROLONGED CYCLE, CONTINUOUS BLEEDING
FOR 11 DAYS ASSOSIATED WITH CLOTS OF SIZE 5X5 CM CHANGING 12 PADS/DAY NOT ASSOSIATED WIT PAIN THEN SHE
CONSULTED PRIVATE CONSULTANT WHERE
SHE PRESCRIBED T. TRANEXA 500 MG [USED FOR 3 WEEKS] AND MEORANTE 1 MG [USED FOR 8 DAYS] BLEEDING SUBSIDED AFTER
USING MEDIACTION. 5 DAYS BACK PASSED
CLOTS OF SIZE 3X3 CM. C/O BURNING MICTURITION SINCE 2DAYS
NO
H/O WHITE DISCHARGE, ABDOMINAL PAIN, DYSPARUNIA, POST COITAL BLEEDING, NO H/O STRESS INCONTINENCE
NO
H/O ABDOINAL DISTENSION, CONSTIPATION, DYSPEPSIA NO H/O FEVER,COUGH, COLD
H/O
WEIGHT LOSS SINCE 1 YR, H/O LOSS OF APPEPTITE SINCE 1 MONTH, H/O DYSPNEA ON WALKING SINCE 1 WEEK, GENERALIZED WEKNESS
SINCE 1 MONTH
NO
H.O WHITE DISCHARGE, ABDOMINAL FAMILY
HISTORY- NOT SIGNIFICANT
ON EXAMINATION
VITALS-
TEMP-
97.5 F F PR- 99 BPM
RR 19 CPM
BP-150/80
MM HG GRBS - 98 MG /DL
SYSTEMIC
EXAMINATION CVS S1 S2 + NO MURMERS P/A SOFT NON TENDER CNS NFND
RS
B/L AE + NVBS COURSE IN HOSPITAL
PATIENT WAS ADMITTED IN OBG DEPARTMENT ON 22/9/23 I/V/O
HEAVY AND PROLONGED CYCLES SINCE 1
MONTH AND WAS PLANNED FOR ENDOMETRIAL BIOPSY ON 23/9/23 AT 7 PM, GM REFERRAL DONE I/V/O UNCONTROLLED
SUGARS, HYPERTENSIVE URGENCY AND THE
CASE HAS BEEN TAKEN OVER BY GM TEAM.
PATIENT
WAS FURTHER INVESTIGATED AND MANAGED CONSERVATIVELY WITH ANTIHYPERTENSIVE ADN ANTIDIABETIC MEDICATIONS AND THE SUGARS ARE
UNDER CONTROL. PATIENT IS BEING
DISCHARED IN HAEMODYNAMICALLY STABLE CONDITION
AND ISADVISED FOPR ENDOMETRIAL BIOPSY.
Investigation
NameValueRangeNameValueRangeCOMPLETE
BLOOD PICTURE (CBP) 22-09-2023 06:46:PMHAEMOGLOBIN7.2
gm/dl15.0-12.0 gm/dlTOTAL COUNT14600 cells/cumm10000-4000 cells/cummNEUTROPHILS68 %80-40
%LYMPHOCYTES23 %40-20 %EOSINOPHILS02 %6-1
%MONOCYTES07
%10-2 %BASOPHILS00 %2-0 %PLATELET COUNT4.95SMEARmicrocytic
hypochromic
anemia with leukocytosis and thrombocytosis.COMPLETE URINE EXAMINATION (CUE) 22-09-2023 06:46:PMCOLOURPale yellowAPPEARANCEClearREACTIONAcidicSP.GRAVITY1.010ALBUMIN++SUGAR++++BILE SALTSNilBILE PIGMENTSNilPUS
CELLS5-6EPITHELIAL CELLS3-4RED BLOOD CELLSNilCRYSTALSNilCASTSNilAMORPHOUS
DEPOSITSAbsentOTHERSNilPOST LUNCH BLOOD SUGAR22-09-2023 06:46:PM469 mg/dl140-0 mg/dlRFT
22-09-2023 06:46:PMUREA52
mg/dl42-12
mg/dlCREATININE1.9 mg/dl1.1-0.6 mg/dlURIC ACID7.2 mg/dl6-2.6 mg/dlCALCIUM9.6 mg/dl10.2-8.6 mg/dlPHOSPHOROUS2.6
mg/dl4.5-2.5 mg/dlSODIUM135 mEq/L145-136 mEq/LPOTASSIUM3.8
mEq/L5.1-3.5 mEq/LCHLORIDE98 mEq/L98-107 mEq/LLIVER FUNCTION
TEST (LFT)
22-09-2023 06:46:PMTotal Bilurubin0.86 mg/dl1-0 mg/dlDirect Bilurubin0.19
mg/dl0.2-
0.0
mg/dlSGOT(AST)49 IU/L31-0 IU/LSGPT(ALT)27 IU/L34-0 IU/LALKALINE PHOSPHATE314 IU/L98-42 IU/LTOTAL PROTEINS7.4
gm/dl8.3-6.4 gm/dlALBUMIN3.72 gm/dl5.2-3.5 gm/dlA/G RATIO1.01T3, T4, TSH 22-09-2023 06:46:PMT30.93 ng/ml1.87-0.87 ng/mlT418.25 micro g/dl12.23-
6.32
micro g/dlTSH1.37 micro Iu/ml5.36-0.34 micro Iu/mlHBsAg-RAPID22-09-2023 06:46:PMNegative Anti HCV Antibodies -
RAPID22-09-2023 06:46:PMNon Reactive RFT 24-09-2023 04:49:AMUREA47 mg/dl42-12 mg/dlCREATININE1.7 mg/dl1.1-0.6
mg/dlURIC ACID6.3 mg/dl6-2.6 mg/dlCALCIUM9.4
mg/dl10.2-8.6 mg/dlPHOSPHOROUS1.7 mg/dl4.5-2.5 mg/dlSODIUM134 mEq/L145-136 mEq/LPOTASSIUM3.6
mEq/L5.1-3.5 mEq/LCHLORIDE98 mEq/L98-107 mEq/LRFT 25-09-2023 04:23:AMUREA62 mg/dl42-12 mg/dlCREATININE2.1
mg/dl1.1-0.6 mg/dlURIC ACID7.4 mg/dl6-2.6
mg/dlCALCIUM9.4 mg/dl10.2-8.6 mg/dlPHOSPHOROUS2.3 mg/dl4.5-2.5 mg/dlSODIUM139 mEq/L145-136
mEq/LPOTASSIUM3.5 mEq/L5.1-3.5 mEq/LCHLORIDE98
mEq/L98-107 mEq/LPOST LUNCH BLOOD SUGAR25-09-2023 04:23:
AM362 mg/dl140-0
mg/dlRFT 26-09-2023 04:46:AMUREA53 mg/dl42-12 mg/dlCREATININE1.9
mg/dl1.1-0.6
mg/dlURIC ACID7.9 mg/dl6-2.6 mg/dlCALCIUM9.9 mg/dl10.2-8.6 mg/dlPHOSPHOROUS3.0 mg/dl4.5-2.5
mg/dlSODIUM138 mEq/L145-136 mEq/LPOTASSIUM4.0
mEq/L5.1-3.5 mEq/LCHLORIDE99 mEq/L98-107 mEq/LRFT 26-09-2023 10:11:PMUREA38 mg/dl42-
12
mg/dlCREATININE1.6 mg/dl1.1-0.6 mg/dlURIC ACID6.8 mg/dl6-2.6 mg/dlCALCIUM9.7
mg/dl10.2-
8.6
mg/dlPHOSPHOROUS2.4 mg/dl4.5-2.5 mg/dlSODIUM138 mEq/L145-136 mEq/LPOTASSIUM4.1 mEq/L5.1-3.5 mEq/LCHLORIDE99 mEq/L98-107
mEq/LRFT 27-09-2023 11:22:PMUREA33 mg/dl42-
12 mg/dlCREATININE1.7 mg/dl1.1-0.6 mg/dlURIC ACID6.5 mg/dl6-2.6
mg/dlCALCIUM10.0 mg/dl10.2-8.6
mg/dlPHOSPHOROUS2.4 mg/dl4.5-2.5 mg/dlSODIUM137 mEq/L145-136 mEq/LPOTASSIUM4.0 mEq/L5.1-3.5
mEq/LCHLORIDE99 mEq/L98-107 mEq/L
ULTASOUND
ABDOMEN IMPRESSION- GRADE 2 FATTY LIVER B/L RAISED ECHOGENICITY OF KIDNEYS, LEFT RENAL CORTICAL CYSTS
2D
ECHO - MILD AR, TRIVIAL AR, TRIVIAL MR, NO RWMA, SCLEROTIC AV, GOOD LV SYSTOLIC FUNCTIONS, GRADE 1 DIASTOLIC
DYSFUNCTION PRESENT
Treatment Given(Enter only
Generic Name)
INJ HAI S/C
TID, 20U --- 20U --- 18U
T. REGESTRON 10
MG PO/OD
T. CLINIDIPINE
10 MG PO/BD
T.
OROFER XT PO/OD CAP NEXPROL PO/OD T.KINPRIDE 1 MG PO/OD
SYP CITRALKA10 ML
IN1 GLASS OF WATER
T.
AUGMENTIN 625 MG PO/BD IVF NS @50
ML/HR
Advice at Discharge
INJ HAI S/C TID,
20U --- 20U --- 18U
T. REGESTRON 10
MG PO/OD
T. CLINIDIPINE
10 MG PO/BD
T.
OROFER XT PO/OD CAP NEXPROL PO/OD T.KINPRIDE 1 MG PO/OD
SYP CITRALKA10
ML IN 1 GLASS OF WATER
Comments
Post a Comment